These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 21894004

  • 1. Endothelin antagonism in patients with nondiabetic chronic kidney disease.
    Dhaun N, Goddard J, Webb DJ.
    Contrib Nephrol; 2011; 172():243-254. PubMed ID: 21894004
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endothelin antagonism and reversal of proteinuric renal disease in humans.
    Barton M.
    Contrib Nephrol; 2011; 172():210-222. PubMed ID: 21894001
    [Abstract] [Full Text] [Related]

  • 4. Role of endothelin in cardiovascular disease.
    Agapitov AV, Haynes WG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endothelin and endothelin antagonists in chronic kidney disease.
    Kohan DE, Barton M.
    Kidney Int; 2014 Nov; 86(5):896-904. PubMed ID: 24805108
    [Abstract] [Full Text] [Related]

  • 8. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease.
    Eroglu E, Kocyigit I, Lindholm B.
    Clin Chim Acta; 2020 Jul; 506():92-106. PubMed ID: 32151622
    [Abstract] [Full Text] [Related]

  • 9. Endothelin in nondiabetic chronic kidney disease: preclinical and clinical studies.
    Culshaw GJ, MacIntyre IM, Dhaun N, Webb DJ.
    Semin Nephrol; 2015 Mar; 35(2):176-87. PubMed ID: 25966349
    [Abstract] [Full Text] [Related]

  • 10. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
    Dhaun N, MacIntyre IM, Kerr D, Melville V, Johnston NR, Haughie S, Goddard J, Webb DJ.
    Hypertension; 2011 Apr; 57(4):772-9. PubMed ID: 21357275
    [Abstract] [Full Text] [Related]

  • 11. Endothelin antagonists and resistant hypertension in chronic kidney disease.
    Moore R, Linas S.
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):432-6. PubMed ID: 20502329
    [Abstract] [Full Text] [Related]

  • 12. Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression.
    Benigni A, Perico N, Remuzzi G.
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):1-6. PubMed ID: 11195041
    [Abstract] [Full Text] [Related]

  • 13. Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
    Dhaun N, Yuzugulen J, Kimmitt RA, Wood EG, Chariyavilaskul P, MacIntyre IM, Goddard J, Webb DJ, Corder R.
    J Am Heart Assoc; 2015 Mar 23; 4(3):e001624. PubMed ID: 25801761
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
    Dhaun N, Melville V, Blackwell S, Talwar DK, Johnston NR, Goddard J, Webb DJ.
    J Am Soc Nephrol; 2013 Jan 23; 24(1):31-6. PubMed ID: 23243212
    [Abstract] [Full Text] [Related]

  • 15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.
    Presse Med; 2002 Nov 09; 31(36):1714-20. PubMed ID: 12467154
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
    Dhaun N, Macintyre IM, Melville V, Lilitkarntakul P, Johnston NR, Goddard J, Webb DJ.
    Hypertension; 2009 Jul 09; 54(1):113-9. PubMed ID: 19506099
    [Abstract] [Full Text] [Related]

  • 17. The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease.
    Raina R, Chauvin A, Chakraborty R, Nair N, Shah H, Krishnappa V, Kusumi K.
    Kidney Dis (Basel); 2020 Jan 09; 6(1):22-34. PubMed ID: 32021871
    [Abstract] [Full Text] [Related]

  • 18. Endothelin: role in hypertension.
    Schiffrin EL.
    Biol Res; 1998 Jan 09; 31(3):199-208. PubMed ID: 9830507
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hypertension in patients with nondiabetic chronic kidney disease.
    Ruzicka M, Burns KD, Culleton B, Tobe SW, Canadian Hypertension Education Program.
    Can J Cardiol; 2007 May 15; 23(7):595-601. PubMed ID: 17534470
    [Abstract] [Full Text] [Related]

  • 20. Endothelin, hypertension and chronic kidney disease: new insights.
    Kohan DE.
    Curr Opin Nephrol Hypertens; 2010 Mar 15; 19(2):134-9. PubMed ID: 20051851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.